Rosiglitazone alleviates the persistent fibrotic phenotype of lesional skin scleroderma fibroblasts.
Shi-wen X; Eastwood M; Stratton RJ; Denton CP; Leask A; Abraham DJ; Rheumatology (Oxford, England), 2010, vol. 49, issue 2, p 259, ISSN 14620332. ISBN 14620332.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef